Walmsley Under Pressure Over GSK’s Strategy

Activist Investor Preparing To Pounce

 
• By Andrew McConaghie
  
GSK HQ
Investors remain unimpressed with GSK's turnaround efforts - but support for Elliott's rebellion is likely to be limited.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip